المؤلفون: Farmer, A D, Wegeberg, Anne-Marie Langmach, Brock, B, Hobson, AR, Mohammed, SD, Scott, S M, Holt, CEMB, Semler, JR, Hasler, W L, Helström, PM

المصدر: Farmer , A D , Wegeberg , A-M L , Brock , B , Hobson , AR , Mohammed , SD , Scott , S M , Holt , CEMB , Semler , JR , Hasler , W L & Helström , PM 2017 , ' Regional gastrointestinal contractility parameters using the wireless motility capsule. ' , Scandinavian Association of Neurogastroenterology and Motility , Copenhagen , Denmark , 24/11/2017 - 24/11/2017 .

وصف الملف: application/pdf

الاتاحة: https://vbn.aau.dk/da/publications/9ffbd70f-1594-4c10-a441-94e0e51fd60a
https://vbn.aau.dk/ws/files/520478205/Poster_in_the_Spotlight_SAGIM_2017_Anne_Marie_L._Wegeberg_2_.pdf

المؤلفون: Farmer, A. D., Wegeberg, A. -ML., Brock, B., Hobson, A. R., Mohammed, S. D., Scott, S. M., Bruckner-Holt, C. E., Semler, J. R., Hasler, W. L., Hellström, Per M., 1954, Drewes, A. M., Brock, C.

المصدر: Alimentary Pharmacology and Therapeutics. 47(3):391-400

وصف الملف: print

URL الوصول: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-341481

المؤلفون: SAROSIEK, I., SELOVER, K. H., KATZ, L. A., SEMLER, J. R., WILDING, G. E., LACKNER, J. M., SITRIN, M. D., KUO, B., CHEY, W. D., HASLER, W. L., KOCH, K. L., PARKMAN, H. P., SAROSIEK, J., MCCALLUM, R. W.

المصدر: Alimentary Pharmacology & Therapeutics ; volume 31, issue 2, page 313-322 ; ISSN 0269-2813 1365-2036

الاتاحة: http://dx.doi.org/10.1111/j.1365-2036.2009.04162.x
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.2009.04162.x
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2036.2009.04162.x

المؤلفون: Abell, T. L., Adams, K. A., Boles, R. G., Bousvaros, A., Chong, S. K. F., Fleisher, D. R., Hasler, W. L., Hyman, P. E., Issenman, R. M., Li, B. U. K., Linder, S. L., Mayer, E. A., Mccallum, R. W., Olden, K., Parkman, H. P., Rudolph, C. D., Taché, Y., Tarbell, S., Vakil, N.

المصدر: Neurogastroenterology & Motility ; volume 20, issue 4, page 269-284 ; ISSN 1350-1925 1365-2982

الاتاحة: http://dx.doi.org/10.1111/j.1365-2982.2008.01113.x
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2982.2008.01113.x
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2982.2008.01113.x

المؤلفون: KUO, B., McCALLUM, R. W., KOCH, K. L., SITRIN, M. D., WO, J. M., CHEY, W. D., HASLER, W. L., LACKNER, J. M., KATZ, L. A., SEMLER, J. R., WILDING, G. E., PARKMAN, H. P.

المصدر: Alimentary Pharmacology & Therapeutics ; volume 27, issue 2, page 186-196 ; ISSN 0269-2813 1365-2036

الاتاحة: http://dx.doi.org/10.1111/j.1365-2036.2007.03564.x
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.2007.03564.x
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2036.2007.03564.x

المؤلفون: Vosoughi, K., Ichkhanian, Y., Jacques, J., Aadam, A. A., Benias, P. C., Law, R., Hasler, W. L., Canakis, A., Ragi, O., Khashab, M. A., +7 additional authors

المصدر: Journal Articles

مصطلحات موضوعية: Gastroenterology

Relation: https://academicworks.medicine.hofstra.edu/publications/6228; https://my.hofstra.edu/hofapps/applications/ezproxy/indexMed.jsp?db_proxy=m&&db_url=www.sciencedirect.com/science/article/pii/S0016510720301024

الاتاحة: https://academicworks.medicine.hofstra.edu/publications/6228
https://my.hofstra.edu/hofapps/applications/ezproxy/indexMed.jsp?db_proxy=m&&db_url=www.sciencedirect.com/science/article/pii/S0016510720301024

المؤلفون: Hasler, W. L., Schoenfeld, P.

المصدر: Alimentary Pharmacology & Therapeutics ; volume 17, issue 8, page 997-1005 ; ISSN 0269-2813 1365-2036

الاتاحة: http://dx.doi.org/10.1046/j.1365-2036.2003.01499.x
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2036.2003.01499.x
https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2036.2003.01499.x

المؤلفون: Hasler, W. L., May, K. P., Wilson, L. A., Van Natta, M., Parkman, H. P., Pasricha, P. J., Koch, K. L., Abell, T. L., McCallum, R. W., Nguyen, L. A., Snape, W. J., Sarosiek, I., Clarke, J. O., Farrugia, G., Calles‐escandon, J., Grover, M., Tonascia, J., Lee, L. A., Miriel, L., Hamilton, F. A., Kim, Yale

مصطلحات موضوعية: gastric emptying, contractility, small bowel and colon transit, scintigraphy, Internal Medicine and Specialties, Health Sciences

وصف الملف: application/pdf

Relation: Hasler, W. L.; May, K. P.; Wilson, L. A.; Van Natta, M.; Parkman, H. P.; Pasricha, P. J.; Koch, K. L.; Abell, T. L.; McCallum, R. W.; Nguyen, L. A.; Snape, W. J.; Sarosiek, I.; Clarke, J. O.; Farrugia, G.; Calles‐escandon, J.; Grover, M.; Tonascia, J.; Lee, L. A.; Miriel, L.; Hamilton, F. A.; Kim, Yale (2018). "Relating gastric scintigraphy and symptoms to motility capsule transit and pressure findings in suspected gastroparesis." Neurogastroenterology & Motility 30(2): n/a-n/a.; http://hdl.handle.net/2027.42/141493; Neurogastroenterology & Motility; Revicki DA, Rentz AM, Dubois D, et al. Development and validation of a patientâ assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther. 2003; 18: 141 â 150.; Szarka LA, Camilleri M, Vella A, et al. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol. 2008; 6: 635 â 643.; Kuo B, McCallum RW, Koch KL, et al. Comparison of gastric emptying of a nondigestible capsule to a radiolabelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther. 2008; 27: 186 â 196.; Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology. 2016; 150: 1380 â 1392.; Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology. 2016; 150: 1393 â 1407.; Parkman HP, Yates K, Hasler WL, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011; 140: 101 â 115.; Parkman HP, Yates K, Hasler WL, et al. Similarities and differences between diabetic and idiopathic gastroparesis. Clin Gastroenterol Hepatol. 2011; 9: 1056 â 1064.; Rao SS, Kuo B, McCallum RW, et al. Investigation of colonic and wholeâ gut transit with wireless manometry capsule and radioopaque markers in constipation. Clin Gastroenterol Hepatol. 2009; 7: 537 â 544.; Camilleri M, Thorne NK, Ringel Y, et al. Wireless pHâ motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil. 2010; 22: 874 â 882.; Arora Z, Parungao JM, Lopez R, Heinlein C, Santisi J, Birgisson S. Clinical utility of wireless motility capsule in patients with suspected multiregional gastrointestinal dysmotility. Dig Dis Sci. 2015; 60: 1350 â 1357.; Kuo B, Maneerattanaporn M, Lee AA, et al. Generalized transit delay on wireless motility capsule testing in patients with clinical suspicion of gastroparesis, small intestinal dysmotility, or slow transit constipation. Dig Dis Sci. 2011; 56: 2928 â 2938.; Rao SS, Mysore K, Attaluri A, Valestin J. Diagnostic utility of wireless motility capsule in gastrointestinal dysmotility. J Clin Gastroenterol. 2011; 45: 684 â 690.; Hasler WL. The use of SmartPill for gastric monitoring. Expert Rev Gastroenterol Hepatol. 2014; 8: 587 â 600.; Kloetzer L, Chey WD, McCallum RW, et al. Motility of the antroduodenum in healthy and gastroparetics characterized by wireless motility capsule. Neurogastroenterol Motil. 2010; 22: 527 â 533.; Coleski R, Wilding GE, Semler JR, Hasler WL. Blunting of colon contractions in diabetics with gastroparesis quantified by wireless motility capsule methods. PLoS ONE. 2015; 10: e0141183.; Pasricha PJ, Colvin R, Yates K, et al. Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol. 2011; 9: 567 â 576.; Barshop K, Staller K, Semler J, Kuo B. Duodenal rather than antral motility contractile parameters correlate with symptom severity in gastroparesis patients. Neurogastroenterol Motil. 2015; 27: 339 â 346.; Hasler WL, May KP, Van Natta ML, et al. Wireless motility capsule gastric and extragastric transit and pressure characteristics in a large patient cohort with gastroparesis symptoms: relation to scintigraphic findings and disease etiology (abstract). Gastroenterology. 2015; 148: S507 â S508.; Hasler WL, May KP, Pasricha PJ, et al. Relation of gastroparesis symptom severity to gastric, small bowel, and colon transit and contraction profiles on wireless motility capsule testing in a large multicenter cohort (abstract). Gastroenterology. 2016; 150: S725.; Sachdeva P, Malhotra N, Pathikonda M, et al. Gastric emptying of solids and liquids for evaluation for gastroparesis. Dig Dis Sci. 2011; 56: 1138 â 1146.; Wang YT, Mohammed SD, Farmer AD, et al. Regional gastrointestinal transit and pH studied in 215 healthy volunteers using the wireless motility capsule: influence of age, gender, study country and testing protocol. Aliment Pharmacol Ther. 2015; 42: 761 â 772.; Hasler WL, Saad RJ, Rao SS, et al. Heightened colon motor activity measured by a wireless capsule in patients with constipation: relation to colon transit and IBS. Am J Physiol Gastrointest Liver Physiol. 2009; 297: G1107 â G1114.; Rentz AM, Kahrilas P, Stanghellini V, et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGIâ SYM) in patients with upper gastrointestinal disorders. Qual Life Res. 2004; 13: 1737 â 1749.; Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996; 110: 1036 â 1042.; Talley NJ, Locke GR, Lahr BD, et al. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut. 2006; 55: 933 â 939.; Cassilly DW, Wang YR, Friedenberg FK, Nelson DB, Maurer AH, Parkman HP. Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy. Digestion. 2008; 78: 144 â 151.; Cremonini F, Mullan BP, Camilleri M, Burton DD, Rank MR. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther. 2002; 16: 1781 â 1790.; Camilleri M, Malagelada JR, Brown ML, Becker G, Zinsmeister AR. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol. 1985; 249: G580 â G585.; Cassilly D, Kantor S, Knight LC, et al. Gastric emptying of a nonâ digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil. 2008; 20: 311 â 319.; Delgadoâ Aros S, Camilleri M, Cremonini F, Ferber I, Stephens D, Burton DD. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology. 2004; 127: 1685 â 1694.; Bharucha AE, Camilleri M, Forstrom LA, Zinsmeister AR. Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin Endocrinol. 2009; 70: 415 â 420.; Hasler WL, Coleski R, Chey WD, et al. Differences in intragastric pH in diabetic vs. idiopathic gastroparesis: relation to degree of gastric retention. Am J Physiolâ Gastrointest Liver Physiol 2008; 294: G1384 â G1391.; Gaddipati KV, Simonian HP, Kresge KM, Boden GH, Parkman HP. Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis. Dig Dis Sci. 2006; 51: 1339 â 1346.; Angeli TR, Cheng LK, Du P, et al. Loss of interstitial cells of Cajal and patterns of gastric dysrhythmia in patients with chronic unexplained nausea and vomiting. Gastroenterology. 2015; 149: 56 â 66.; Kumar A, Attaluri A, Hashmi S, Schulze KS, Rao SS. Visceral hypersensitivity and impaired accommodation in refractory diabetic gastroparesis. Neurogastroenterol Motil. 2008; 20: 635 â 642.; Karamanolis G, Caenepeel P, Arts J, Tack J. Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction? Gut. 2007; 56: 29 â 36.; MacGregor IL, Gueller R, Watts HD, Mayer JH. The effect of acute hyperglycemia on gastric emptying in man. Gastroenterology. 1976; 70: 190 â 196.; Pasricha PJ, Yates KP, Nguyen L, et al. Outcomes and factors associated with reduced symptoms in patients with gastroparesis. Gastroenterology. 2015; 149: 1762 â 1774.; Boccia G, Buonavolontà R, Coccorullo P, Manguso F, Fuiano L, Staiano A. Dyspeptic symptoms in children: the result of a constipationâ induced cologastric brake? Clin Gastroenterol Hepatol. 2008; 6: 556 â 560.; Hasler WL. Gastroparesis: pathogenesis, diagnosis and management. Nat Rev Gastroenterol Hepatol. 2011; 8: 438 â 453.; Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008; 103: 753 â 763.; Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000; 95: 1456 â 1462.

الاتاحة: http://hdl.handle.net/2027.42/141493
https://doi.org/10.1111/nmo.13196

المؤلفون: Wang, Y. T., Mohammed, S. D., Farmer, A. D., Wang, D., Zarate, N., Hobson, A. R., Hellström, P. M., Semler, J. R., Kuo, B., Rao, S. S., Hasler, W. L., Camilleri, M., Scott, S. M.

المصدر: Alimentary Pharmacology and Therapeutics. 42(6):761-772

وصف الملف: print

URL الوصول: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-262408

المؤلفون: Parkman, H. P., Hallinan, E. K., Hasler, W. L., Farrugia, G., Koch, K. L., Nguyen, L., Snape, W. J., Abell, T. L., McCallum, R. W., Sarosiek, I., Pasricha, P. J., Clarke, J., Miriel, L., Tonascia, J., Hamilton, F.

مصطلحات موضوعية: gastroparesis, early satiety, gastric emptying, diabetic gastroparesis, Internal Medicine and Specialties, Health Sciences

وصف الملف: application/pdf

Relation: Parkman, H. P.; Hallinan, E. K.; Hasler, W. L.; Farrugia, G.; Koch, K. L.; Nguyen, L.; Snape, W. J.; Abell, T. L.; McCallum, R. W.; Sarosiek, I.; Pasricha, P. J.; Clarke, J.; Miriel, L.; Tonascia, J.; Hamilton, F. (2017). "Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing." Neurogastroenterology & Motility 29(4): n/a-n/a.; https://hdl.handle.net/2027.42/136370; Neurogastroenterology & Motility; Revicki DA, Rentz AM, Dubois D, et al. Development and validation of a patient‐assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther. 2003; 18: 141 – 150.; Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004; 127: 1592 – 1622.; Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long‐term follow‐up of patients with gastroparesis. Dig Dis Sci. 1998; 43: 2398 – 2404.; Nguyen LA, Snape WJ Jr. Clinical presentation and pathophysiology of gastroparesis. Gastroenterol Clin North Am. 2015; 44: 21 – 30.; Revicki DA, Camilleri M, Kuo B, Szarka LA, McCormack J, Parkman HP. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index‐Daily Diary (GCSI‐DD). Neurogastroenterol Motil. 2012; 24: 456 – 463.; Hui R. Gastroparesis: Clinical Evaluation of Drugs for Treatment: Guidance for Industry. Food and Drug Administration Center for Drug Evaluation and Research (CDER); 2015. Available at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm455645.pdf. Accessed October 6, 2016.; Kelly KA. Gastric emptying of liquids and solids: roles of proximal and distal stomach. Am J Physiol. 1980; 239: G71 – G76.; Collins PJ, Horowitz M, Chatterton BE. Proximal, distal and total stomach emptying of a digestible solid meal in normal subjects. Br J Radiol. 1988; 61: 12 – 18.; Azpiroz F. Control of gastric emptying by gastric tone. Dig Dis Sci. 1994; 39: 18S – 19S.; Troncon LE, Bennett RJ, Ahluwalia NK, Thompson DG. Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients. Gut. 1994; 35: 327 – 332.; Tack J, Piessevaux H, Coulie B, et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998; 115: 1346 – 1352.; Karamanolis G, Caenepeel P, Arts J, Tack J. Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction? Gut. 2007; 56: 29 – 36.; Stanghellini V, Tack J. Gastroparesis: separate entity or just a part of dyspepsia? Gut. 2014; 63: 1972 – 1978.; Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996; 110: 1036 – 1042.; Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol. 2003; 98: 783 – 788.; Parkman HP, Yates K, Hasler WL, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011; 140: 101 – 115.; Hasler WL, Parkman HP, Wilson LA, et al. Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis. Am J Gastroenterol. 2010; 105: 2357 – 2367.; Abell TL, Bernstein VK, Cutts T, et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil. 2006; 18: 263 – 283.; Rentz AM, Kahrilas P, Stanghellini V, et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI‐SYM) in patients with upper gastrointestinal disorders. Qual Life Res. 2004; 13: 1737 – 1749.; SAS Institute, Inc. SAS Software, Version 9.3 of the SAS System for Windows. Cary, NC, 2002‐2010. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP; 2011.; De la Loge C, Trudeau E, Marquis P, et al. Cross‐cultural development and validation of a patient self‐administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI‐QOL. Qual Life Res. 2004; 13: 1751 – 1762.; Ware JE, Kosinski M, Dewey JE. How to Score Version 2 of the SF‐36® Health Survey. Lincoln, RI: QualityMetric Incorporated; 2000.; Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000; 95: 1456 – 1462.; Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy. Am J Gastroenterol. 2008; 103: 753 – 763.; Sachdeva P, Malhotra N, Pathikonda M, et al. Gastric emptying of solids and liquids for evaluation for gastroparesis. Dig Dis Sci. 2011; 56: 1138 – 1146.; Koch KL, Hong SP, Xu L. Reproducibility of gastric myoelectrical activity and the water load test in patients with dysmotility‐like dyspepsia symptoms and in control subjects. J Clin Gastroenterol. 2000; 31: 125 – 129.; Agresti A. Categorical Data Analysis. New York, NY: John Wiley & Sons, Inc.; 1990.; Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974; 19: 716 – 723.; Hosmer D, Lemeshow S. Applied Logistic Regression, 2nd edn. New York, NY: John Wiley & Sons, Inc.; 2000.; Vijayvargiya P, Camilleri M, Shin A, Breen M, Burton D. Simplifying the measurement of gastric accommodation using SPECT. Neurogastroenterol Motil. 2013; 25: 542 – 546.; Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology. 2016; 150: 1380 – 1392.; Yu D, Ramsey FV, Norton W, Norton N, Gaetano T, Parkman HP. Impaired quality of life in gastroparesis: relationships to symptoms of gastroparesis. Gastroenterology 2016; 150: S718.

الاتاحة: https://hdl.handle.net/2027.42/136370
https://doi.org/10.1111/nmo.12981

المؤلفون: Grover, M., Bernard, C. E., Pasricha, P. J., Parkman, H. P., Gibbons, S. J., Tonascia, J., Koch, K. L., McCallum, R. W., Sarosiek, I., Hasler, W. L., Nguyen, L. A. B., Abell, T. L., Snape, W. J., Kendrick, M. L., Kellogg, T. A., McKenzie, T. J., Hamilton, F. A., Farrugia, G.

مصطلحات موضوعية: interstitial cells of Cajal, macrophages, gastrointestinal motility, immune cells, enteric nervous system, Internal Medicine and Specialties, Health Sciences

وصف الملف: application/pdf

Relation: Grover, M.; Bernard, C. E.; Pasricha, P. J.; Parkman, H. P.; Gibbons, S. J.; Tonascia, J.; Koch, K. L.; McCallum, R. W.; Sarosiek, I.; Hasler, W. L.; Nguyen, L. A. B.; Abell, T. L.; Snape, W. J.; Kendrick, M. L.; Kellogg, T. A.; McKenzie, T. J.; Hamilton, F. A.; Farrugia, G. (2017). "Diabetic and idiopathic gastroparesis is associated with loss of CD206‐positive macrophages in the gastric antrum." Neurogastroenterology & Motility 29(6): n/a-n/a.; https://hdl.handle.net/2027.42/137212; Neurogastroenterology & Motility; Horvath VJ, Vittal H, Lorincz A, et al. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of Cajal in murine diabetic gastroparesis. Gastroenterology. 2006; 130: 759 – 770.; Grover M, Farrugia G, Lurken MS, et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology. 2011; 140: 1575 – 1585 e8.; Faussone‐Pellegrini MS, Grover M, Pasricha PJ, et al. Ultrastructural differences between diabetic and idiopathic gastroparesis. J Cell Mol Med. 2012; 16: 1573 – 1581.; Battaglia E, Bassotti G, Bellone G, et al. Loss of interstitial cells of Cajal network in severe idiopathic gastroparesis. World J Gastroenterol. 2006; 12: 6172 – 6177.; Pasricha PJ, Pehlivanov ND, Gomez G, Vittal H, Lurken MS, Farrugia G. Changes in the gastric enteric nervous system and muscle: a case report on two patients with diabetic gastroparesis. BMC Gastroenterol. 2008; 8: 21.; Iwasaki H, Kajimura M, Osawa S, et al. A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus. J Gastroenterol. 2006; 41: 1076 – 1087.; Choi KM, Kashyap PC, Dutta N, et al. CD206‐positive M2 macrophages that express heme oxygenase‐1 protect against diabetic gastroparesis in mice. Gastroenterology. 2010; 138: 2399 – 2409, 409 e1.; Cipriani G, Gibbons SJ, Verhulst PJ, et al. Diabetic Csf1op/op mice lacking macrophages are protected against the development of delayed gastric emptying. Cell Mol Gastroenterol Hepatol. 2016; 2: 40 – 47.; Neshatian L, Gibbons SJ, Farrugia G. Macrophages in diabetic gastroparesis–the missing link? Neurogastroenterol Motil. 2015; 27: 7 – 18.; Bernard CE, Gibbons SJ, Mann IS, et al. Association of low numbers of CD206‐positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesis. Neurogastroenterol Motil. 2014; 26: 1275 – 1284.; Thumshirn M, Bruninga K, Camilleri M. Simplifying the evaluation of postprandial antral motor function in patients with suspected gastroparesis. Am J Gastroenterol. 1997; 92: 1496 – 1500.; Kawagishi T, Nishizawa Y, Okuno Y, et al. Antroduodenal motility and transpyloric fluid movement in patients with diabetes studied using duplex sonography. Gastroenterology. 1994; 107: 403 – 409.; Fraser RJ, Horowitz M, Maddox AF, Dent J. Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis–effects of cisapride. Gut. 1994; 35: 172 – 178.; Ordog T, Ward SM, Sanders KM. Interstitial cells of Cajal generate electrical slow waves in the murine stomach. J Physiol. 1999; 518: 257 – 269.; Forrest AS, Ordog T, Sanders KM. Neural regulation of slow‐wave frequency in the murine gastric antrum. Am J Physiol Gastrointest Liver Physiol. 2006; 290: G486 – G495.; Zhang CM, Huang X, Lu HL, et al. Up‐regulation of the Ang II/AT1 receptor may compensate for the loss of gastric antrum ICC via the PI3k/Akt signaling pathway in STZ‐induced diabetic mice. Mol Cell Endocrinol. 2016; 426: 77 – 86.; Wang XY, Huizinga JD, Diamond J, Liu LW. Loss of intramuscular and submuscular interstitial cells of Cajal and associated enteric nerves is related to decreased gastric emptying in streptozotocin‐induced diabetes. Neurogastroenterol Motil. 2009; 21: 1095 – e92.; Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008; 103: 753 – 763.; Harberson J, Thomas RM, Harbison SP, Parkman HP. Gastric neuromuscular pathology in gastroparesis: analysis of full‐thickness antral biopsies. Dig Dis Sci. 2010; 55: 359 – 370.; Othman MO, Davis B, Saroseik I, Torabi A, McCallum RW. EUS‐guided FNA biopsy of the muscularis propria of the antrum in patients with gastroparesis is feasible and safe. Gastrointest Endosc. 2016; 83: 327 – 333.; Lin Z, Sarosiek I, Forster J, Damjanov I, Hou Q, McCallum RW. Association of the status of interstitial cells of Cajal and electrogastrogram parameters, gastric emptying and symptoms in patients with gastroparesis. Neurogastroenterol Motil. 2010; 22: 56 – 61 e10.; Ordog T, Takayama I, Cheung WK, Ward SM, Sanders KM. Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes. 2000; 49: 1731 – 1739.; Long QL, Fang DC, Shi HT, Luo YH. Gastro‐electric dysrhythm and lack of gastric interstitial cells of Cajal. World J Gastroenterol. 2004; 10: 1227 – 1230.; Grover M, Bernard CE, Pasricha PJ, et al. Clinical‐histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium. Neurogastroenterol Motil. 2012; 24: 531 – 539.; Cipriani G, Gibbons SJ, Kashyap PC, Farrugia G. Intrinsic gastrointestinal macrophages: their phenotype and role in gastrointestinal motility. Cell Mol Gastroenterol Hepatol. 2016; 2: 120 – 130 e1.; Bain CC, Scott CL, Uronen‐Hansson H, et al. Resident and pro‐inflammatory macrophages in the colon represent alternative context‐dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol. 2013; 6: 498 – 510.; Tamoutounour S, Henri S, Lelouard H, et al. CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1‐inducing role of mesenteric lymph node macrophages during colitis. Eur J Immunol. 2012; 42: 3150 – 3166.; Raes G, Van den Bergh R, De Baetselier P, et al. Arginase‐1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J Immunol. 2005; 174: 6561; author reply ‐2.; Gross TJ, Kremens K, Powers LS, et al. Epigenetic silencing of the human NOS2 gene: rethinking the role of nitric oxide in human macrophage inflammatory responses. J Immunol. 2014; 192: 2326 – 2338.; Choi KM, Gibbons SJ, Nguyen TV, et al. Heme oxygenase‐1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology. 2008; 135: 2055 – 2064, 64 e1‐2.; Kashyap PC, Choi KM, Dutta N, et al. Carbon monoxide reverses diabetic gastroparesis in NOD mice. Am J Physiol Gastrointest Liver Physiol. 2010; 298: G1013 – G1019.; Choi KM, Sha L, Verhulst P‐J, et al. Treatment with IL‐10 reverses gastroparesis in diabetic NOD/Shiltj mice. Gastroenterology. 2012; 142: S‐66.; Deng B, Wehling‐Henricks M, Villalta SA, Wang Y, Tidball JG. IL‐10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J Immunol. 2012; 189: 3669 – 3680.; Asadullah K, Sterry W, Volk HD. Interleukin‐10 therapy–review of a new approach. Pharmacol Rev. 2003; 55: 241 – 269.

الاتاحة: https://hdl.handle.net/2027.42/137212
https://doi.org/10.1111/nmo.13018

المؤلفون: Farmer, A D, Wegeberg, A-M L, Brock, B, Hobson, A R, Mohammed, S D, Scott, S M, Bruckner-Holt, C E, Semler, J R, Hasler, W L, Hellström, P M, Drewes, A M, Brock, C

المصدر: Farmer , A D , Wegeberg , A-M L , Brock , B , Hobson , A R , Mohammed , S D , Scott , S M , Bruckner-Holt , C E , Semler , J R , Hasler , W L , Hellström , P M , Drewes , A M & Brock , C 2018 , ' Regional gastrointestinal contractility parameters using the wireless motility capsule : inter-observer reproducibility and influence of age, gender and study country ' , Alimentary Pharmacology and Therapeutics , vol. 47 , no. 3 , pp. 391-400 .

مصطلحات الفهرس: Journal Article, article

URL: https://curis.ku.dk/portal/da/publications/regional-gastrointestinal-contractility-parameters-using-the-wireless-motility-capsule(1bf7c10c-fc3d-407c-93c8-2ef9bd48003c).html
https://doi.org/10.1111/apt.14438

المؤلفون: Rao, S S C, Camilleri, M, Hasler, W L, Maurer, A H, Parkman, H P, Saad, R, Scott, M S, Simrén, Magnus, 1966, Soffer, E, Szarka, L

المصدر: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 23(1):8-23

مصطلحات موضوعية: Gastroenterology and Hepatology, Gastroenterologi och hepatologi

URL الوصول: https://gup.ub.gu.se/publication/131423

المؤلفون: Koch, K. L., Hasler, W. L., Yates, K. P., Parkman, H. P., Pasricha, P. J., Calles‐escandon, J., Snape, W. J., Abell, T. L., McCallum, R. W., Nguyen, L. A., Sarosiek, I., Farrugia, G., Tonascia, J., Lee, L., Miriel, L., Hamilton, F.

مصطلحات موضوعية: nausea and vomiting, hyperglycemia, gastroparesis, gastric emptying, type 1 and type 2 diabetes mellitus, Internal Medicine and Specialties, Health Sciences

وصف الملف: application/pdf

Relation: Koch, K. L.; Hasler, W. L.; Yates, K. P.; Parkman, H. P.; Pasricha, P. J.; Calles‐escandon, J.; Snape, W. J.; Abell, T. L.; McCallum, R. W.; Nguyen, L. A.; Sarosiek, I.; Farrugia, G.; Tonascia, J.; Lee, L.; Miriel, L.; Hamilton, F. (2016). "Baseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1 vs type 2 diabetes." Neurogastroenterology & Motility (7): 1001-1015.; https://hdl.handle.net/2027.42/122408; Neurogastroenterology & Motility; De la Loge C, Trudeau E, Marquis P, Kahrilas P, Stanghellini V, Talley NJ, Tack J, Revicki DA et al. Crossâ cultural development and validation of a patient selfâ administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGIâ QOL. Qual Life Res 2004; 13: 1751 â 62.; Jung HK, Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Szarka LA, Mullan B, Talley NJ. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmstead County, Minnesota, from 1996 to 2006. Gastroenterology 2009; 136: 1225 â 33.; Jones KL, Russo A, Berry MK, Stevens JE, Wishart JM, Horowitz M. A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus. Am J Med 2002; 113: 449 â 55.; Chang J, Rayner CK, Jones KL, Horowitz M. Prognosis of diabetic gastroparesisâ a 25 year evaluation. Diabet Med 2013; 30: e185 â 8.; Pasricha PJ, Yates KP, Nguyen L, Clarke J, Abell TL, Farrugia G, Hasler WL, Koch KL et al. Outcomes and factors associated with reduced symptoms in patients with pastroparesis. Gastroenterology 2015; 149: 1762 â 74. Doi:10.1053/j.gastro.2015.08.008.; Daneman D. Type 1 diabetes mellitus. Lancet 2006; 367: 847 â 58.; Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T, Berglund G, Altshuler D. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008; 359: 2220 â 32.; Horowitz M, Maddox AF, Wishart JM, Harding PE, Chatterton BE, Shearman DJ. Relationships between esophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nuc Med 1991; 18: 229 â 34.; Keshavarzian A, Iber FL, Vaeth J. Gastric emptying in patients with insulinâ requiring diabetes mellitus. Am J Gastroenterol 1987; 82: 29 â 35.; Horowitz M, Harding PE, Maddox AF, Wishart JM, Akkermans LM, Chatterton BE, Shearman DJ. Gastric and esophageal emptying in patients with type 2 (noninsulinâ dependent) diabetes mellitus. Diabetologia 1989; 32: 151 â 9.; Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Melton LJ, Talley NJ. Risk of gastroparesis in subjects with type 1 and type 2 diabetes in the general population. Am J Gastroenterol 2012; 107: 82 â 8.; Dickman R, Kislov J, Boaz M, Ron Y, Beniashvili Z, Raz I, Baigel I, Niv Y et al. Prevalence of symptoms suggestive of gastroparesis in a cohort of patients with diabetes mellitus. J Diab Comp 2013; 27: 376 â 9.; Kofodâ Andersen K, Tarnow L. Prevalence of gastroparesisâ related symptoms in an unselected cohort of patients with type 1 diabetes. J Diab Comp 2012; 26: 89 â 93.; Grover M, Farrugia G, Lurken MS, Bernard CE, Faussoneâ Pellegrini MS, Smyrk TC, Parkman HP, Abell TL et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology 2011; 140: 1575 â 85.; Rentz AM, Kahrilas P, Stanghellini V, Tack J, Talley NJ, de la Loge C, Trudeau E, Dubois D et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGIâ SYM) in patients with upper gastrointestinal disorders. Qual Life Res 2004; 13: 1737 â 49.; Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Development and validation of a patientâ assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003; 18: 141 â 50.; Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, McCallum RW, Nowak T et al. Consensus recommendations for gastric emptying scintigraphy. A joint report of the Society of Nuclear Medicine and The American Neurogastroenterology and Motility Society. Am J Gastroenterology 2008; 103: 753 â 63.; Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the Beck Depression Inventory. A review. Psychopathology 1998; 31: 160 â 8.; Spielberger C, Gorsuch R, Lushene R. Manual for the Stateâ Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.; Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998; 316: 1236 â 8.; Ware JE, Kosinski M, Dewey JE. How to Score Version 2 of the SFâ 36® Health Survey. Lincoln, RI: QualityMetric Incorporated, 2000.; Agresti A. Categorical Data Analysis, 2nd edn. Hoboken, NJ: John Wiley and Sons Inc, 2002.; Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd edn. Hoboken, NJ: John Wiley and Sons Inc, 2000.; McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 1947; 12: 153 â 7.; Fleiss JL, Leven B, Paik MC. Statistical Methods for Rates and Proportions, 3rd edn. Hoboken, NJ: John Wiley and Sons, Inc., 2003: 374 â 80.; Draper N, Smith H. Applied Regression Analysis, 3rd edn. Hoboken, NJ: John Wiley and Sons Inc, 1998.; Rosenbaum PR. Observational Studies, 3rd edn. New York, NY: Springer, 2010.; Cao J, Zhang S. Multiple comparison procedures. JAMA 2014; 312: 543 â 4.; Bender R, Lange S. Adjusting for multiple testing: when and how? J Clin Epidemiol 2001; 54: 343 â 9.; Parkman HP, Yates K, Hasler WL, Nguyen L, Pasricha PJ, Snape WJ, Farrugia G, Koch KL et al. Similarities and differences between diabetic and idiopathic gastroparesis. Clin Gastroenterol Hepatol 2011; 9: 1056 â 64.; Kumar A, Attaluri A, Hashmi S, Schulze KS, Rao SS. Visceral hypersensitivity and impaired accommodation in refractory diabetic gastroparesis. Neurogastroenterol Motil 2008; 20: 635 â 42.; Koch KL, Stern RM, Stewart WR, Vasey MW. Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of longâ term domperidone treatment. Am J Gastroenterol 1989; 84: 1069 â 75.; Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986; 90: 1919 â 25.; Parkman HP, Yates KP, Hasler WL, Nguyan L, Pasricha PJ, Snape WJ, Farrugia G, Calles J et al. Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesis. Gastroenterology 2011; 141: 486 â 98.; Grover M, Bernard CE, Pasricha PJ, Lurken MS, Faussoneâ Pellegrini MS, Smyrk TC, Parkman HP, Abell TL et al. Clinicalâ histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium. Neurogastroenterol Moâ til 2012; 24: 531 â 9.; Hasler WL. Methods of gastric electrical stimulation and pacing: a review of their benefits and mechanisms of action in gastroparesis and obesity. Neurogastroenterol Motil 2009; 21: 229 â 43.; Camilleri M. Clinical practice. Diabetic gastroparesis. N Engl J Med 2007; 356: 820 â 9.; Abell TL, Bernstein VK, Cutts T, Farrugia G, Forster J, Hasler WL, McCallum RW, Olden KW et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 2006; 18: 263 â 83.; Hasler WL, Wilson LA, Parkman HP, Nguyen L, Abell TL, Koch KL, Pasricha PJ, Snape WJ et al. Bloating in gastroparesis: severity, impact, and associated factors. Am J Gastroenterol 2011; 106: 1492 â 502.; Hasler WL, Wilson LA, Parkman HP, Koch KL, Abell TL, Nguyen L, Pasricha PJ, Snape WJ et al. Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting. Neurogastroenterol Motil 2013; 25: 427 â 38.; Tougas G, Eaker EY, Abell TL, Abrahamsson H, Boivin M, Chen J, Hocking MP, Quigley EM et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000; 95: 1456 â 62.; Pasricha PJ, Colvin R, Yates K, Hasler WL, Abell TL, Unalpâ Arida A, Nguyen L, Farrugia G et al. Characteristics of patients with chronic nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol 2011; 9: 567 â 76.; Janssen P, Harris MS, Jones M, Masaoka T, Farré R, Törnblom H, Van Oudenhove L, Simrén M et al. The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. Am J Gastroenterol 2013; 108: 1382 â 91.; Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum RW. Demography, clinical characteristics, psychological and abuse profiles, treatment, and longâ term follow up of patients with gastroparesis. Dig Dis Sci 1998; 43: 2398 â 404.; Fraser RJ, Horowitz M, Maddox AF, Harding PE, Chatterton BE, Dent J. Hyperglycemia slows gastric emptying in type 1 (insulinâ dependent) diabetes mellitus. Diabetologia 1990; 33: 675 â 80.; Hebbard GS, Samsom M, Sun WM, Dent J, Horowitz M. Hyperglycemia affects proximal gastric motor and sensory function during small intestinal triglyceride infusion. Am J Physiol 1996; 271: G814 â 9.; Hasler WL, Parkman HP, Wilson LA, Pasricha PJ, Koch KL, Abell TL, Snape WJ, Farrugia G et al. Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis. Am J Gastroenterol 2010; 105: 2357 â 67.; Kashyap P, Farrugia G. Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut 2010; 59: 1716 â 26.; Ramzan Z, Duffy F, Gomez J, Fisher RS, Parkman HP. Continuous glucose monitoring in gastroparesis. Dig Dis Sci 2011; 56: 2646 â 55.; Hyett B, Martinez FJ, Gill BM, Mehra S, Lembo A, Kelly CP, Leffler DA. Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis. Gastroenterology 2009; 137: 445 â 52.

الاتاحة: https://hdl.handle.net/2027.42/122408
https://doi.org/10.1111/nmo.12800

المؤلفون: Parkman, H. P., Hallinan, E. K., Hasler, W. L., Farrugia, G., Koch, K. L., Calles, J., Snape, W. J., Abell, T. L., Sarosiek, I., McCallum, R. W., Nguyen, L., Pasricha, P. J., Clarke, J., Miriel, L., Lee, L., Tonascia, J., Hamilton, F.

مصطلحات موضوعية: gastric emptying, diabetic gastroparesis, gastroparesis, Nausea, vomiting, Internal Medicine and Specialties, Health Sciences

وصف الملف: application/pdf

Relation: Parkman, H. P.; Hallinan, E. K.; Hasler, W. L.; Farrugia, G.; Koch, K. L.; Calles, J.; Snape, W. J.; Abell, T. L.; Sarosiek, I.; McCallum, R. W.; Nguyen, L.; Pasricha, P. J.; Clarke, J.; Miriel, L.; Lee, L.; Tonascia, J.; Hamilton, F. (2016). "Nausea and vomiting in gastroparesis: similarities and differences in idiopathic and diabetic gastroparesis." Neurogastroenterology & Motility 28(12): 1902-1914.; https://hdl.handle.net/2027.42/134969; Neurogastroenterology & Motility; Cherian D, Parkman HP. Nausea and vomiting in diabetic and idiopathic gastroparesis. Neurogastroenterol Motil 2012; 24: 217 – 22.; Parkman HP, Yates K, Hasler WL, Nguyen L, Pasricha PJ, Snape WJ, Farrugia G, Koch KL et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology 2011; 140: 101 – 15.; Hasler WL, Parkman HP, Wilson LA, Pasricha PJ, Koch KL, Abell TL, Snape WJ, Farrugia G et al. Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis. Am J Gastroenterol 2010; 105: 2357 – 67.; Abell TL, Bernstein RK, Cutts T, Farrugia G, Forster J, Hasler WL, McCallum RW, Olden KW et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 2006; 18: 263 – 83.; Rentz AM, Kahrilas P, Stanghellini V, Tack J, Talley NJ, de la Loge C, Trudeau E, Dubois D et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI‐SYM) in patients with upper gastrointestinal disorders. Qual Life Res 2004; 13: 1737 – 49.; Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Development and validation of a patient‐assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003; 18: 141 – 50.; Camilleri M. Diabetic gastroparesis. N Engl J Med 2007; 356: 820 – 9.; Sachdeva P, Malhotra N, Pathikonda M, Khayyam U, Fisher RS, Maurer AH, Parkman HP. Gastric emptying of solids and liquids for evaluation for gastroparesis. Dig Dis Sci 2011; 56: 1138 – 46.; Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, McCallum RW, Nowak T et al. Consensus recommendations for gastric emptying scintigraphy. Am J Gastroenterol 2008; 103: 753 – 63.; Tougas G, Eaker EY, Abell TL, Abrahamsson H, Boivin M, Chen J, Hocking MP, Quigley EM et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000; 95: 1456 – 62.; Muth ER, Stern RM, Thayer JF, Koch KL. Assessment of the multiple dimensions of nausea: the Nausea Profile (NP). J Psychosom Res 1996; 40: 511 – 20.; Ware JE, Kosinski M, Dewey JE. How to Score Version 2 of the SF‐36 ® Health Survey. Lincoln, RI: QualityMetric Incorporated, 2000.; De la Loge C, Trudeau E, Marquis P, Kahrilas P, Stanghellini V, Talley NJ, Tack J, Revicki DA et al. Cross‐cultural development and validation of a patient self‐administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI‐QOL. Qual Life Res 2004; 13: 1751 – 62.; Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127: 1592 – 622.; Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum RW. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long‐term follow‐up of patients with gastroparesis. Dig Dis Sci 1998; 43: 2398 – 404.; Jaffe JK, Paladugu S, Gaughan JP, Parkman HP. Characteristics of nausea and its effects on quality of life in diabetic and idiopathic gastroparesis. J Clin Gastroenterol 2011; 45: 317 – 21.; Pasricha PJ, Colvin R, Yates K, Hasler WL, Abell TL, Ünalp‐Arida A, Nguyen L, Farrugia G et al. Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol 2011; 9: 567 – 76.e1‐4.; Hasler WL, Coleski R, Chey WD, Koch KL, McCallum RW, Wo JM, Kuo B, Sitrin MD, Katz LA et al. Differences in intragastric pH in diabetic versus idiopathic gastroparesis: relation to degree of gastric retention. Am J Physiol 2008; 294: G1384 – 91.; Simonian HP, Kresge KM, Boden GH, Parkman HP. Differential effects of sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels: evidence for vagal efferent stimulation mediating ghrelin release. Neurogastroenterol Motil 2005; 17: 348 – 54.; Hasler WL. Pathology of emesis: its autonomic basis. Handb Clin Neurol 2013; 117: 337 – 52.; Parkman HP, Yates K, Hasler WL, Nguyen L, Pasricha PJ, Snape WJ, Farrugia G, Koch KL et al. Similarities and differences between diabetic and idiopathic gastroparesis. Gastroenterology 2011; 9: 1056 – 64.; SAS Institute, Inc. SAS software, version 9.3 of the SAS system for Windows. Cary, NC, 2002‐2010. Stata statistical software: release 12. College Station, TX: StataCorp LP, 2011.; Hosmer D, Lemeshow S. Applied Logistic Regression, 2nd edn. New York: John Wiley & Sons, Inc., 2000.; Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control 1974; 19: 716 – 23.; Agresti A. Categorical Data Analysis. New York: John Wiley & Sons, Inc., 1990.

الاتاحة: https://hdl.handle.net/2027.42/134969
https://doi.org/10.1111/nmo.12893

المؤلفون: Bernard, C. E., Gibbons, S. J., Mann, I. S., Froschauer, L., Parkman, H. P., Harbison, S., Abell, T. L., Snape, W. J., Hasler, W. L., McCallum, R. W., Sarosiek, I., Nguyen, L. A. B., Koch, K. L., Tonascia, J., Hamilton, F. A., Kendrick, M. L., Shen, K. R., Pasricha, P. J., Farrugia, G.

مصطلحات موضوعية: Interstitial Cells of Cajal, Gastroparesis, Macrophages, Internal Medicine and Specialties, Health Sciences

وصف الملف: application/pdf

Relation: Bernard, C. E.; Gibbons, S. J.; Mann, I. S.; Froschauer, L.; Parkman, H. P.; Harbison, S.; Abell, T. L.; Snape, W. J.; Hasler, W. L.; McCallum, R. W.; Sarosiek, I.; Nguyen, L. A. B.; Koch, K. L.; Tonascia, J.; Hamilton, F. A.; Kendrick, M. L.; Shen, K. R.; Pasricha, P. J.; Farrugia, G. (2014). "Association of low numbers of CD 206‐positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesis." Neurogastroenterology & Motility 26(9): 1275-1284.; http://hdl.handle.net/2027.42/108285; Neurogastroenterology & Motility; Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery‐induced weight loss. Diabetes 2005; 54: 2277 – 86.; Faussone‐Pellegrini MS, Grover M, Pasricha PJ, Bernard CE, Lurken MS, Smyrk TC, Parkman HP, Abell TL, et al. Ultrastructural differences between diabetic and idiopathic gastroparesis. J Cell Mol Med 2012; 16: 1573 – 81.; Grover M, Bernard CE, Pasricha PJ, Lurken MS, Faussone‐Pellegrini MS, Smyrk TC, Parkman HP, Abell TL, et al. Clinical‐histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium. Neurogastroenterol Motil 2012; 24: 531 – 9, e249.; Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981; 11: 805 – 15.; Mikkelsen HB. Interstitial cells of Cajal, macrophages and mast cells in the gut musculature: morphology, distribution, spatial and possible functional interactions. J Cell Mol Med 2010; 14: 818 – 32.; Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958 – 69.; Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23 – 35.; Albina JE. On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukoc Biol 1995; 58: 643 – 9.; Gross TJ, Kremens K, Powers LS, Brink B, Knutson T, Domann FE, Philibert RA, Milhem MM, et al. Epigenetic silencing of the human NOS2 gene: rethinking the role of nitric oxide in human macrophage inflammatory responses. J Immunol 2014; 192: 2326 – 38.; Micklem K, Rigney E, Cordell J, Simmons D, Stross P, Turley H, Seed B, Mason D. A human macrophage‐associated antigen (CD68) detected by six different monoclonal antibodies. Br J Haematol 1989; 73: 6 – 11.; Kunisch E, Fuhrmann R, Roth A, Winter R, Lungershausen W, Kinne RW. Macrophage specificity of three anti‐CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis 2004; 63: 774 – 84.; Adams CW, Poston RN. Macrophage histology in paraffin‐embedded multiple sclerosis plaques is demonstrated by the monoclonal pan‐macrophage marker HAM‐56: correlation with chronicity of the lesion. Acta Neuropathol 1990; 80: 208 – 11.; Gown AM, Tsukada T, Ross R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 1986; 125: 191 – 207.; Hamann J, Koning N, Pouwels W, Ulfman LH, van Eijk M, Stacey M, Lin HH, Gordon S, et al. EMR1, the human homolog of F4/80, is an eosinophil‐specific receptor. Eur J Immunol 2007; 37: 2797 – 802.; Kalff JC, Schwarz NT, Walgenbach KJ, Schraut WH, Bauer AJ. Leukocytes of the intestinal muscularis: their phenotype and isolation. J Leukoc Biol 1998; 63: 683 – 91.; Mikkelsen HB, Rumessen JJ. Characterization of macrophage‐like cells in the external layers of human small and large intestine. Cell Tissue Res 1992; 270: 273 – 9.; Kalff JC, Turler A, Schwarz NT, Schraut WH, Lee KK, Tweardy DJ, Billiar TR, Simmons RL, et al. Intra‐abdominal activation of a local inflammatory response within the human muscularis externa during laparotomy. Ann Surg 2003; 237: 301 – 15.; Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 1994; 35: 669 – 74.; He CL, Soffer EE, Ferris CD, Walsh RM, Szurszewski JH, Farrugia G. Loss of interstitial cells of cajal and inhibitory innervation in insulin‐dependent diabetes. Gastroenterology 2001; 121: 427 – 34.; Vittal H, Farrugia G, Gomez G, Pasricha PJ. Mechanisms of disease: the pathological basis of gastroparesis–a review of experimental and clinical studies. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 336 – 46.; Battaglia E, Bassotti G, Bellone G, Dughera L, Serra AM, Chiusa L, Repici A, Mioli P, et al. Loss of interstitial cells of Cajal network in severe idiopathic gastroparesis. World J Gastroenterol 2006; 12: 6172 – 7.; Forster J, Damjanov I, Lin Z, Sarosiek I, Wetzel P, McCallum RW. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg 2005; 9: 102 – 8.; Harberson J, Thomas RM, Harbison SP, Parkman HP. Gastric neuromuscular pathology in gastroparesis: analysis of full‐thickness antral biopsies. Dig Dis Sci 2010; 55: 359 – 70.; Iwasaki H, Kajimura M, Osawa S, Kanaoka S, Furuta T, Ikuma M, Hishida A. A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus. J Gastroenterol 2006; 41: 1076 – 87.; Pasricha PJ, Pehlivanov ND, Gomez G, Vittal H, Lurken MS, Farrugia G. Changes in the gastric enteric nervous system and muscle: a case report on two patients with diabetic gastroparesis. BMC Gastroenterol 2008; 8: 21.; Zarate N, Mearin F, Wang XY, Hewlett B, Huizinga JD, Malagelada JR. Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management. Gut 2003; 52: 966 – 70.; McKnight AJ, Macfarlane AJ, Dri P, Turley L, Willis AC, Gordon S. Molecular cloning of F4/80, a murine macrophage‐restricted cell surface glycoprotein with homology to the G‐protein‐linked transmembrane 7 hormone receptor family. J Biol Chem 1996; 271: 486 – 9.; Baud V, Chissoe SL, Viegas‐Pequignot E, Diriong S, N'Guyen VC, Roe BA, Lipinski M. EMR1, an unusual member in the family of hormone receptors with seven transmembrane segments. Genomics 1995; 26: 334 – 44.; Khazen W, M'Bika JP, Tomkiewicz C, Benelli C, Chany C, Achour A, Forest C. Expression of macrophage‐selective markers in human and rodent adipocytes. FEBS Lett 2005; 579: 5631 – 4.; Gough PJ, Gordon S, Greaves DR. The use of human CD68 transcriptional regulatory sequences to direct high‐level expression of class A scavenger receptor in macrophages in vitro and in vivo. Immunology 2001; 103: 351 – 61.; Fowler LJ, Maygarden SJ, Novotny DB. Human alveolar macrophage‐56 and carcinoembryonic antigen monoclonal antibodies in the differential diagnosis between primary ovarian and metastatic gastrointestinal carcinomas. Hum Pathol 1994; 25: 666 – 70.; Beranek JT. CD68 is not a macrophage‐specific antigen. Ann Rheum Dis 2005; 64: 342 – 3; author reply 3‐4.; Gottfried E, Kunz‐Schughart LA, Weber A, Rehli M, Peuker A, Muller A, Kastenberger M, Brockhoff G, et al. Expression of CD68 in non‐myeloid cell types. Scand J Immunol 2008; 67: 453 – 63.; Villalta SA, Nguyen HX, Deng B, Gotoh T, Tidball JG. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet 2009; 18: 482 – 96.; Denis M. Human monocytes/macrophages: NO or no NO? J Leukoc Biol 1994; 55: 682 – 4.; Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405 – 12.; Cummings TJ, Hulette CM, Bigner SH, Riggins GJ, McLendon RE. Ham56‐immunoreactive macrophages in untreated infiltrating gliomas. Arch Pathol Lab Med 2001; 125: 637 – 41.; Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. Clinical guideline: management of gastroparesis. Am J Gastroenterol 2013; 108: 18 – 37; quiz 8.; Wang YR, Fisher RS, Parkman HP. Gastroparesis‐related hospitalizations in the United States: trends, characteristics, and outcomes, 1995‐2004. Am J Gastroenterol 2008; 103: 313 – 22.; Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Szarka LA, Mullan B, Talley NJ. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009; 136: 1225 – 33.; Bielefeldt K. Gastroparesis: concepts, controversies, and challenges. Scientifica (Cairo) 2012; 2012: 424802.; Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127: 1592 – 622.; Hasler WL. Gastroparesis–current concepts and considerations. Medscape J Med 2008; 10: 16.; Spangeus A, Suhr O, El‐Salhy M. Diabetic state affects the innervation of gut in an animal model of human type 1 diabetes. Histol Histopathol 2000; 15: 739 – 44.; Wang XY, Huizinga JD, Diamond J, Liu LW. Loss of intramuscular and submuscular interstitial cells of Cajal and associated enteric nerves is related to decreased gastric emptying in streptozotocin‐induced diabetes. Neurogastroenterol Motil 2009; 21: 1095 – e92.; Ordog T, Takayama I, Cheung WK, Ward SM, Sanders KM. Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes 2000; 49: 1731 – 9.; Horvath VJ, Vittal H, Lorincz A, Chen H, Almeida‐Porada G, Redelman D, Ordog T. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis. Gastroenterology 2006; 130: 759 – 70.; Choi KM, Gibbons SJ, Nguyen TV, Stoltz GJ, Lurken MS, Ordog T, Szurszewski JH, Farrugia G. Heme oxygenase‐1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology 2008; 135: 2055 – 64, 64 e1‐2.; Choi KM, Kashyap PC, Dutta N, Stoltz GJ, Ordog T, Shea Donohue T, Bauer AJ, Linden DR, et al. CD206‐positive M2 macrophages that express heme oxygenase‐1 protect against diabetic gastroparesis in mice. Gastroenterology 2010; 138: 2399 – 409, 409 e1.; Grover M, Farrugia G, Lurken MS, Bernard CE, Faussone‐Pellegrini MS, Smyrk TC, Parkman HP, Abell TL, et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology 2011; 140: 1575 – 85 e8.

الاتاحة: http://hdl.handle.net/2027.42/108285
https://doi.org/10.1111/nmo.12389

المؤلفون: Hasler, W. L., Wilson, L. A., Parkman, H. P., Koch, K. L., Abell, T. L., Nguyen, L., Pasricha, P. J., Snape, W. J., McCallum, R. W., Sarosiek, I., Farrugia, G., Calles, J., Lee, L., Tonascia, J., Unalp‐arida, A., Hamilton, F.

مصطلحات موضوعية: Psychological Dysfunction, Opiates, Gastroparesis, Gastric Emptying, Diabetes Mellitus, Quality of Life, Internal Medicine and Specialties, Health Sciences

وصف الملف: application/pdf

Relation: Hasler, W. L.; Wilson, L. A.; Parkman, H. P.; Koch, K. L.; Abell, T. L.; Nguyen, L.; Pasricha, P. J.; Snape, W. J.; McCallum, R. W.; Sarosiek, I.; Farrugia, G.; Calles, J.; Lee, L.; Tonascia, J.; Unalp‐arida, A.; Hamilton, F. (2013). "Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting." Neurogastroenterology & Motility 25(5): 427-e301.; https://hdl.handle.net/2027.42/97520; Neurogastroenterology & Motility; Hasler WL, Parkman HP, Wilson LA et al. Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis. Am J Gastroenterol 2010; 105: 2357 – 67.; Stanghellini V, Tosetti C, Horowitz M et al. Predictors of gastroparesis in out‐patients with secondary and idiopathic upper gastrointestinal symptoms. Dig Liver Dis 2003; 35: 389 – 96.; Khayyam U, Sachdeva P, Gomez J et al. Assessment of symptoms during gastric emptying scintigraphy to correlate symptoms to delayed gastric emptying. Neurogastroenterol Motil 2010; 22: 539 – 45.; Jones KL, Wishart JM, Russo A, Wishart JM, Berry MK, Horowitz M. Predictors of delayed gastric emptying in diabetes. Diabetes Care 2001; 24: 1264 – 9.; Samsom M, Vermeijden JR, Smout AJ et al. Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: a prospective study in unselected diabetic patients. Diabetes Care 2003; 26: 3116 – 22.; Silvers D, Kipnes M, Broadstone V et al. Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality‐of‐life outcomes in a multicenter controlled trial. DOM‐USA‐5 Study Group. Clin Ther 1998; 20: 438 – 53.; Abell T, McCallum R, Hocking M et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003; 125: 421 – 8.; Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466 – 79.; Tougas G, Eaker EY, Abell TL et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000; 95: 1456 – 62.; Rentz AM, Kahrilas P, Stanghellini V et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI‐SYM) in patients with upper gastrointestinal disorders. Qual Life Res 2004; 13: 1737 – 49.; Revicki DA, Rentz AM, Dubois D et al. Development and validation of a patient‐assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003; 18: 141 – 50.; De la Loge C, Trudeau E, Marquis P et al. Cross‐cultural development and validation of a patient self‐administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI‐QOL. Qual Life Res 2004; 13: 1751 – 62.; Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the beck depression inventory. A review. Psychopathology 1998; 31: 160 – 8.; Spielberger C, Gorsuch R, Lushene R. Manual for the State‐Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.; Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 1998; 17: 873 – 90.; SAS software, version 9.3 of the SAS system for Windows, Cary, NC: SAS Institute, Inc, 2011.; Stata statistical software. release 11. College Station, TX: StataCorp, 2009.; Parkman HP, Yates K, Hasler WL et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology 2011; 140: 101 – 15.; Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979 – 88.; Tack J, Demedts I, Dehondt G et al. Clinical and pathophysiological characteristics of acute‐onset functional dyspepsia. Gastroenterology 2002; 122: 1738 – 47.; Van Oudenhove L, Vandenberghe J, Geeraerts B et al. Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation? Gut 2008; 57: 1666 – 73.; Alok R, Das SK, Agarwal GG, Salwahan L, Srivastava R. Relationship of severity of depression, anxiety and stress with severity of fibromyalgia. Clin Exp Rheumatol 2011; 29 ( 6 Suppl 69 ): S70 – 2.; Pasricha PJ, Colvin R, Yates K et al. Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol 2011; 9: 567 – 76.; Drossman DA, Toner BB, Whitehead WE et al. Cognitive‐behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003; 125: 19 – 31.; Tack J, Sarnelli G. Serotonergic modulation of visceral sensation: upper gastrointestinal tract. Gut 2002; 51 ( Suppl 1 ): 77 – 80.; Revicki DA, Camilleri M, Kuo B, Szarka LA, McCormack J, Parkman HP. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index‐Daily Diary (GCSI‐DD). Neurogastroenterol Motil 2012; 24: 456 – 63.; Maranki JL, Lytes V, Meilahn JE et al. Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis. Dig Dis Sci 2008; 53: 2072 – 8.; Harrell SP, Studts JL, Dryden GW, Eversmann L, Cai L, Wo JM. A novel classification scheme for gastroparesis based on predominant‐symptom presentation. J Clin Gastroenterol 2008; 42: 455 – 9.; MacGregor IL, Gueller R, Watts HD, Meyer JH. The effect of acute hyperglycemia on gastric emptying in man. Gastroenterology 1976; 70: 190 – 6.; Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121: 526 – 35.; Kumar A, Attaluri A, Hashmi S, Schulze KS, Rao SS. Visceral hypersensitivity and impaired accommodation in refractory diabetic gastroparesis. Neurogastroenterol Motil 2008; 20: 635 – 42.; Kuo B, Maneerattanaporn M, Lee AA et al. Generalized transit delay on wireless motility capsule testing in patients with clinical suspicion of gastroparesis, small intestinal dysmotility, or slow transit constipation. Dig Dis Sci 2011; 56: 2928 – 38.; Rao SS, Mysore K, Attaluri A, Valestin J. Diagnostic utility of wireless motility capsule in gastrointestinal motility. J Clin Gastroenterol 2011; 45: 684 – 90.; Abell TL, Familoni B, Voeller G et al. Electrophysiologic, morphologic, and serologic features of chronic nausea and vomiting: lessons learned from 121 consecutive patients. Surgery 2009; 145: 476 – 85.; Bromer MQ, Friedenberg F, Miller LS, Fisher RS, Swartz K, Parkman HP. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 2005; 61: 833 – 9.; Forstner‐Barthell AW, Murr MM, Nitecki S et al. Near‐total completion gastrectomy for severe postvagotomy gastric stasis: analysis of early and long‐term results in 62 patients. J Gastrointest Surg 1999; 3: 15 – 21.; Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127: 1592 – 622.; Abell TL, Bernstein RK, Cutts T et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 2006; 18: 263 – 83.; Cherian D, Sachdeva P, Fisher RS, Parkman HP. Abdominal pain is a frequent symptom of gastroparesis. Clin Gastroenterol Hepatol 2010; 8: 676 – 81.; Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum RW. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long‐term follow‐up of patients with gastroparesis. Dig Dis Sci 1998; 43: 2398 – 404.; Karamanolis G, Caenepeel P, Arts J, Tack J. Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction? Gut 2007; 56: 29 – 36.; Hoogerwerf WA, Pasricha PJ, Kalloo AN, Schuster MM. Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol 1999; 94: 1029 – 33.; Bielefeldt K, Raza N, Zickmund SL. Different faces of gastroparesis. World J Gastroenterol 2009; 15: 6052 – 60.; Anaparthy R, Pehlivanov N, Grady J, Yimei H, Pasricha PJ. Gastroparesis and gastroparesis‐like syndrome: response to therapy and its predictors. Dig Dis Sci 2009; 54: 1003 – 10.; Briley LC, Harrell SP, Woosley A, Eversmann J, Wo JM. National survey of physicians' perception of the cause, complications, and management of gastroparesis. South Med J 2011; 104: 412 – 7.; Kindt S, Dubois D, Van Oudenhove L et al. Relationship between symptom pattern, assessed by the PAGI‐SYM questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia. Neurogastroenterol Motil 2009; 21: 1183‐e105.

الاتاحة: https://hdl.handle.net/2027.42/97520
https://doi.org/10.1111/nmo.12091

المؤلفون: Grover, M., Bernard, C. E., Pasricha, P. J., Lurken, M. S., Faussone-Pellegrini, M. S., Smyrk, T. C., Parkman, H. P., Abell, T. L., Snape, W. J., Hasler, W. L., Mccallum, R. W., Nguyen, L., Koch, K. L., Calles, J., Lee, L., Tonascia, J., Uenalp-Arida, A., Hamilton, F. A., Farrugia, G.

المصدر: Grover , M , Bernard , C E , Pasricha , P J , Lurken , M S , Faussone-Pellegrini , M S , Smyrk , T C , Parkman , H P , Abell , T L , Snape , W J , Hasler , W L , Mccallum , R W , Nguyen , L , Koch , K L , Calles , J , Lee , L , Tonascia , J , Uenalp-Arida , A , Hamilton , F A , Farrugia , G & NIDDK Gastroparesis Clinical Res 2012 , ' Clinical-histological associations in gastroparesis ....

مصطلحات موضوعية: clinical symptoms, enteric nervous system, gastric emptying, gastroparesis, interstitial cells of Cajal, macrophages, NITRIC-OXIDE SYNTHASE, GASTRIC-EMPTYING SCINTIGRAPHY, ENTERIC NERVOUS-SYSTEM, INTERSTITIAL-CELLS, DIABETIC GASTROPARESIS, PATHOLOGICAL FINDINGS, FUNCTIONAL DYSPEPSIA, CAJAL, SYMPTOMS, MELLITUS

الاتاحة: https://hdl.handle.net/11370/f05c792a-4198-460e-9406-99970b18621e
https://research.rug.nl/en/publications/f05c792a-4198-460e-9406-99970b18621e
https://doi.org/10.1111/j.1365-2982.2012.01894.x

المؤلفون: Camilleri, M., Thorne, N. K., Ringel, Y., Hasler, W. L., Kuo, B., Esfandyari, T., Gupta, A., Scott, S. M., Mccallum, R. W., Parkman, H. P., Soffer, E., Wilding, G. E., Semler, J. R., Rao, S. S.c.

المصدر: Neurogastroenterology and Motility, 22(8)

مصطلحات موضوعية: colonic transit time, negative agreement, correlation, wireless motility capsule, radiopaque markers, positive agreement

Relation: https://doi.org/10.17615/ya8t-h409; https://cdr.lib.unc.edu/downloads/5m60r1019?file=thumbnail; https://cdr.lib.unc.edu/downloads/5m60r1019

الاتاحة: https://doi.org/10.17615/ya8t-h409
https://cdr.lib.unc.edu/downloads/5m60r1019?file=thumbnail
https://cdr.lib.unc.edu/downloads/5m60r1019

المؤلفون: kloetzer, l., chey, w. d., mccallum, r. w., koch, k. l., wo, j. m., sitrin, m., katz, l. a., lackner, j. m., parkman, h. p., wilding, g. e., semler, j. r., hasler, w. l., kuo, b.

المصدر: Neurogastroenterology & Motility ; ISSN 1350-1925 1365-2982

الاتاحة: http://dx.doi.org/10.1111/j.1365-2982.2010.01468.x
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2982.2010.01468.x
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2982.2010.01468.x/fullpdf